Questcor Execs Hid Athcor Woes To Pad Price, Suit Says
A Questcor Pharmaceuticals Inc. shareholder on Thursday lodged a derivative complaint against the company's top executives, accusing them of lying about the efficacy of their main drug to inflate the price...To view the full article, register now.
Already a subscriber? Click here to view full article